bezafibrate has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birtwistle, J; Bunce, CM; Davies, NJ; Delgado, J; Drayson, MT; Hayden, RE; Khanim, FL; Pearce, C; Pratt, G; Sant, T | 1 |
1 other study(ies) available for bezafibrate and 15-deoxy-delta(12,14)-prostaglandin j2
Article | Year |
---|---|
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
Topics: Apoptosis; Bezafibrate; CD40 Ligand; Cell Proliferation; Drug Combinations; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Mitochondrial Proteins; Prostaglandin D2; Reactive Oxygen Species; Signal Transduction; Superoxides; Tumor Cells, Cultured | 2009 |